PROGNOSTIC IMPLICATION OF IPSS AND IPSS-R FOR PATIENTS WITH LOWER-RISK MDS TREATED WITH HYPOMETHYLATING AGENTS

被引:0
|
作者
Moon, J. H. [1 ]
Sohn, S. K. [1 ]
Sook, A. Jae [2 ]
Kim, H. J. [2 ]
Song, M. K. [3 ]
Chung, J. S. [3 ]
Lim, S. N. [4 ]
Bae, S. H. [5 ]
机构
[1] Kyungpook Natl Univ Hosp, Deagu, South Korea
[2] Cheonnam Natl Univ, Hwasun Hosp, Cheonnam, South Korea
[3] Busan Natl Univ Hosp, Pusan, South Korea
[4] Inje Univ, Paik Hosp, Pusan, South Korea
[5] Daegu Catholic Univ, Med Ctr, Deagu, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P919
引用
收藏
页码:345 / 346
页数:2
相关论文
共 50 条
  • [11] Revised International Prognostic Scoring System (IPSS-R), stratification for myelodysplastic syndrome (MDS) patients under hypomethylating treatment
    Iastrebner, M.
    Flores, G.
    Nucifora, E.
    Kornblihtt, L.
    Alfonso, G.
    Rosenhain, M.
    Benasayag, S.
    Barcala, V.
    Garcia Rivello, H.
    Belli, C.
    LEUKEMIA RESEARCH, 2013, 37 : S85 - S85
  • [12] NO BENEFIT OF HYPOMETHYLATING AGENTS COMPARED TO SUPPORTIVE CARE FOR HIGHER RISK MYELODYSPLASTIC SYNDROME BY IPSS-R
    Lee, Y.
    Sohn, S.
    Ahn, J.
    Kim, H. J.
    Shin, H. J.
    Lee, H. S.
    Suh, J.
    Do, Y. R.
    Kim, B. S.
    LEUKEMIA RESEARCH, 2017, 55 : S65 - S65
  • [13] Revised International Prognostic Scoring System (IPSS-R) for MDS: Update
    Greenberg, P.
    Tuechler, H.
    LEUKEMIA RESEARCH, 2013, 37 : S3 - S3
  • [14] Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine
    Cluzeau, Thomas
    Mounier, Nicolas
    Karsenti, Jean-Michel
    Richez, Valentine
    Legros, Laurence
    Gastaud, Lauris
    Garnier, Georges
    Re, Daniel
    Montagne, Nathalie
    Gutnecht, Jean
    Fuzibet, Jean Gabriel
    Auberger, Patrick
    Raynaud, Sophie
    Cassuto, Jill-Patrice
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (09) : 780 - 783
  • [15] Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry
    de Swart, Louise
    Smith, Alex
    Johnston, Thomas W.
    Haase, Detlef
    Droste, Jackie
    Fenaux, Pierre
    Symeonidis, Argiris
    Sanz, Guillermo
    Hellstroem-Lindberg, Eva
    Cermak, Jaroslav
    Germing, Ulrich
    Stauder, Reinhard
    Georgescu, Otilia
    MacKenzie, Marius
    Malcovati, Luca
    Holm, Mette S.
    Almeida, Antonio M.
    Madry, Krzysztof
    Slama, Borhane
    Guerci-Bresler, Agnes
    Sanhes, Laurence
    Beyne-Rauzy, Odile
    Luno, Elisa
    Bowen, David
    de Witte, Theo
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (03) : 372 - 383
  • [16] Cytogenetic abnormalities in primary MDS: Incidence and classification according to cytogenetic risk groups defined by the IPSS and IPSS-R
    Silva, M.
    Azevedo Neto, R.
    Leal, A.
    Ferreira, P.
    Kumeda, C.
    Tanizawa, R.
    Mascarenhas, A.
    Lima, W.
    Buccheri, V.
    Velloso, E.
    LEUKEMIA RESEARCH, 2013, 37 : S71 - S71
  • [17] THE IPSS-R HAS PROGNOSTIC IMPACT IN UNTREATED PATIENTS WITH MDS DEL(5Q)
    Schemenau, J.
    Lauseker, M.
    Hildebrandt, B.
    Fenaux, P.
    Pfeilstoecker, M.
    Valent, P.
    Platzbecker, U.
    Kuendgen, A.
    Bug, G.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2015, 39 : S157 - S157
  • [18] The IPSS-R has prognostic impact in untreated patients with MDS del(5q)
    Kaivers, J.
    Lauseker, M.
    Hildebrandt, B.
    Fenaux, P.
    Pfeilstoecker, M.
    Valent, P.
    Platzbecker, U.
    Latagliata, R.
    Oliva, E. N.
    Xicoy, B.
    Goetze, K.
    Ganster, C.
    Haase, D.
    Bug, G.
    Kuendgen, A.
    Gattermann, N.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2018, 72 : 27 - 33
  • [19] Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS)
    Gangat, Naseema
    Patnaik, Mrinal M.
    Begna, Kebede
    Kourelius, Taxiarchis
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Hodnefield, Janice M.
    Hanson, Curtis A.
    Pardanani, Animesh
    Tefferi, Ayalew
    BLOOD, 2012, 120 (21)
  • [20] Genomic Microarray Alterations Add Prognostic Power to the IPSS-R in MDS with Normal Karyotype
    Mallo, Mar
    Tuechler, Heinz
    Shih, Lee-Yung
    Ogawa, Seishi
    Sanada, Masashi
    Lin, Tung-Liang
    Ganster, Christina
    Shirneshan, Katayoon
    Haase, Detlef
    Lopez-Pavia, Maria
    Cervera, Jose
    Such, Esperanza
    Arenillas, Leonor
    Garcia, Olga
    Adema, Vera
    Palomo, Laura
    Mascaro, Marti
    Luno, Elisa
    Maria Raya, Jose
    Greenberg, Peter L.
    Ebert, Benjamin L.
    Sole, Francesc
    BLOOD, 2014, 124 (21)